source
- Tango plans Phase 3 pancreatic cancer study after combo successWill 2026 be remembered as the year when pancreatic cancer finally became treatable? Following Revolution Medicines’ smashing success at the annual American Society of Clinical Oncology meeting las…Endpoints · 1mo ago↗ source
- Coming SoonNext installments of the biopharma pay series coming soonEndpoints · 1mo ago↗ source
- STAT+: Novo underwhelmed by drug it once fought Pfizer forRevolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech newsSTAT · 1mo ago↗ source